Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1350809-21-0

C18H20BrClN2 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1350809-21-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1350809-21-0 Structure

  • Basic information

    1. Product Name: C18H20BrClN2
    2. Synonyms:
    3. CAS NO:1350809-21-0
    4. Molecular Formula:
    5. Molecular Weight: 379.727
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1350809-21-0.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: C18H20BrClN2(CAS DataBase Reference)
    10. NIST Chemistry Reference: C18H20BrClN2(1350809-21-0)
    11. EPA Substance Registry System: C18H20BrClN2(1350809-21-0)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1350809-21-0(Hazardous Substances Data)

1350809-21-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1350809-21-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,5,0,8,0 and 9 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1350809-21:
(9*1)+(8*3)+(7*5)+(6*0)+(5*8)+(4*0)+(3*9)+(2*2)+(1*1)=140
140 % 10 = 0
So 1350809-21-0 is a valid CAS Registry Number.

1350809-21-0Downstream Products

1350809-21-0Relevant articles and documents

Design and synthesis of pyridin-2-ylmethylaminopiperidin-1-ylbutyl amide CCR5 antagonists that are potent inhibitors of M-tropic (R5) HIV-1 replication

Skerlj, Renato,Bridger, Gary,Zhou, Yuanxi,Bourque, Elyse,McEachern, Ernest,Langille, Jonathan,Harwig, Curtis,Veale, Duane,Yang, Wen,Li, Tongshong,Zhu, Yongbao,Bey, Michael,Baird, Ian,Sartori, Michael,Metz, Markus,Mosi, Renee,Nelson, Kim,Bodart, Veronique,Wong, Rebecca,Fricker, Simon,Mac Farland, Ron,Huskens, Dana,Schols, Dominique

, p. 6950 - 6954 (2012/01/13)

A series of CCR5 antagonists were optimized for potent inhibition of R5 HIV-1 replication in peripheral blood mononuclear cells. Compounds that met acceptable ADME criteria, selectivity, human plasma protein binding, potency shift in the presence of α-glycoprotein were evaluated in rat and dog pharmacokinetics.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1350809-21-0